<?xml version="1.0" encoding="utf-8"?><!-- generator="wordpress/2.3.2" -->
<rss version="0.92">
<channel>
	<title>Pharmaceutical News</title>
	<link>http://breakingnewsblog.com/pharmaceutical</link>
	<description></description>
	<lastBuildDate>Mon, 22 May 2006 06:11:58 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Sigma Pharmaceuticals year profit rises 27 pct</title>
		<description><![CDATA[
&#8216;Australian drugs firm Sigma Pharmaceuticals Ltd. reported a 27 percent rise in underlying annual profit, as expected, boosted by its takeover of Arrow, and reaffirmed its outlook for the year ahead.
Drugs manufacturer and distributor Sigma snared Arrow for its pipeline of generic drugs, a high margin business seen as a hot source of growth in [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/sigma_pharmaceuticals_year_profit_rises_27_pct/</link>
			</item>
	<item>
		<title>South African citizens cheap drug guinea pigs</title>
		<description><![CDATA[
&#8221;Come to South Africa and use our people as cheap guinea pigs for drugs trials,&#8221; says an international pharmaceutical testing company.
Even as a young South African backpacker is battling to recover in a London hospital after a drug trial gone horribly wrong, a senior employee at the pharmaceutical company that ran the drug trial is [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/south_african_citizens_cheap_drug_guinea_pigs/</link>
			</item>
	<item>
		<title>Two drugs test victims face a year in coma</title>
		<description><![CDATA[
&#8216;Two men critically ill following the drug-tests disaster could remain in a coma for up to a year.
They are among six men still in intensive care at a London hospital after suffering horrendous reactions to injections in private clinical trials for a German pharmaceutical company.
The four others are believed to have started communicating by making [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/two_drugs_test_victims_face_a_year_in_coma/</link>
			</item>
	<item>
		<title>Can drug companies improve their reputation?</title>
		<description><![CDATA[
&#8216;Drug dealers were once favorite movie bad guys. These days, it&#8217;s drug companies. That Hollywood can manufacture a plausible storyline in which a major drug firm commits all manner of corruption and even murder, speaks volumes about the American public&#8217;s already deep mistrust of drugmakers.
A 2005 poll by the Kaiser Family Foundation found that 7 [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/can_drug_companies_improve_their_reputation/</link>
			</item>
	<item>
		<title>Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts</title>
		<description><![CDATA[
&#8216;Pfizer Inc. said 2006 net income will rise 40 percent as the world&#8217;s largest drugmaker enters the second year of a $4 billion cost-cutting plan.
Earnings this year will rise to $11.4 billion to $11.7 billion, or $1.52 to $1.56 a share, from $8.09 billion, or $1.09, in 2005, Pfizer said today in a statement as [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/pfizer_sees_40_percent_rise_in_2006_net_on_cost_cuts/</link>
			</item>
	<item>
		<title>Pfizer&#8217;s Forecast Disappoints</title>
		<description><![CDATA[
&#8216;Pfizer (PFE:NYSE - news - research - Cramer&#8217;s Take) said Friday that 2006 will yield flat sales and slightly lower earnings per share, but the drug giant indicated that its top-line growth should resume in 2007 as new drugs more than offset the loss of patents on its existing medications.
The company is looking for what [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/pfizers_forecast_disappoints/</link>
			</item>
	<item>
		<title>Pharmaceutical RFID Adoption Stalls</title>
		<description><![CDATA[
&#8216;Analysts had been optimistic about the potential of using RFID technology to track pharmaceuticals, thereby curbing theft and counterfeiting while encouraging supply chain efficiency.
In fact, last year technology market research firm ABI Research estimated that the shipments of life sciences RFID transponders would more than triple by the end of this year.
But new state legislation [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/pharmaceutical_rfid_adoption_stalls/</link>
			</item>
	<item>
		<title>Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients</title>
		<description><![CDATA[
&#8216;Diabetes is fast becoming a serious global problem. No surprise, then, that a lot of folks cheered after learning that a new drug option &#8212; the first inhaled form of insulin &#8212; will soon hit pharmacy shelves.
The drug, called Exubera, provides an option for diabetes patients who are supposed to inject themselves with insulin three [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/inhalable_drug_might_bring_sigh_of_relief_to_diabetes_patients/</link>
			</item>
	<item>
		<title>GlaxoSmithKline unveils best results since merger</title>
		<description><![CDATA[
&#8216;GlaxoSmithKline sought to reassure investors yesterday by announcing it would file its potential blockbuster cervical cancer vaccine, Cervarix, for approval in the US before the end of the year.
The news came after the British pharmaceuticals giant unveiled its best annual performance since 2000 when it was formed from the merger of SmithKline Beecham and Glaxo [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/_glaxosmithkline_unveils_best_results_since_merger/</link>
			</item>
	<item>
		<title>Pfizer Sues Teva, Sandoz Over Zithromax</title>
		<description><![CDATA[
&#8216;Pfizer Inc. has filed a patent infringement suit against generic drug makers Teva Pharmaceutical Industries Ltd. and Sandoz Inc. concerning generic versions of the antibiotic Zithromax.
Representatives from Sandoz, based in Princeton, N.J., and Teva, based in Israel, couldn&#8217;t immediately be reached for comment.
In a press release Wednesday, Pfizer also said it filed a petition with [...]]]></description>
		<link>http://breakingnewsblog.com/pharmaceutical/archives/pfizer_sues_teva_sandoz_over_zithromax/</link>
			</item>
</channel>
</rss>
